Combined protein C deficiency and protein C activated resistance as a cause of caval, peripheral, and cerebral venous thrombosis: A case report

Angiology

Volumn 49, Issue 5, 1998, Pages 399-401

  Pugliese, Domenico ^a,b   Nicoletti, Giuseppe ^a   Andreula, Cosma ^a   Ciccone, Marco ^b   Triggiani, Giovanni ^a  

^a UNIVERSITY OF BARI   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; GESTODENE; PROTEIN C;

ADULT; ARTICLE; CASE REPORT; COLOR ULTRASOUND FLOWMETRY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; OCCLUSIVE CEREBROVASCULAR DISEASE; ONSET AGE; ORAL CONTRACEPTION; PREVALENCE; PROTEIN C DEFICIENCY; RISK ASSESSMENT; SCREENING TEST;

EID: 0031863259     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979804900509     Document Type: Article

References (13)

1. Kalbag RM, Woolf AL: Cerebral venous thrombosis. Vol. 1. London: University Press, 1967.
2. Daif A, Adnan A, Al-Rajeh S, et al: Cerebral venous thrombosis in adults. A study of 40 cases from Saudi Arabia. Stroke 26:1193-1195, 1995.
3. Conard J, Horellou MH, Samama M: Incidence of thromboembolism in association with congenital disorders in coagulation and fibrinolysis. Acta Chir Scand 543(suppl):15-25, 1988.
4. Coller BS, Owen J, Jesty J, et al: Deficiency of plasma protein S, protein C, or antithrombin III and arterial thrombosis. Arteriosclerosis 7:456-462, 1987.
5. Kohler J, Kasper J, Witt I, von Reutern GM: Ischemic stroke due to protein C deficiency. Stroke 21:1077-1080, 1990.
6. Matsushita K, Kuriyama Y, Sawada T, Uchida K: Cerebral infarction associated with protein C deficiency. Stroke 23:108-111, 1992.
7. Wintzen AR, Broekmans AW, Bertina RM, et al: Cerebral hemorrhagic infarction in young patients with hereditary protein C deficiency: Evidence for spontaneous cerebral venous thrombosis. Br Med J 290:350-352, 1985.
8. Heligren M, Svensson PJ, Dahlback B: Resistance to activated C protein as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol 173:210-213, 1995.
9. Svensson PJ, Dahalback B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517-521, 1994.
10. Zoller B, Dahalback B: Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet 343:1536-1538, 1994.
11. Halbmayer WM, Haushofer A, Schon R, Fisher M: The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects. Blood Coagul Fibrinolysis 5: 51-57, 1994.
12. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception: Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case-control study. Lancet 346: 1575-1582, 1995.
13. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception: Effect of different progestagens in low estrogen oral contraceptives on venous thromboembolic disease. Lancet 346:1582-1588, 1995.